| 2017/12/22 |  |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
Overseas Regulatory Announcement
|
| 2017/12/22 | |
VERY SUBSTANTIAL ACQUISITION
IN RELATION TO THE PROPOSED ACQUISITION OF
30% OF THE EQUITY INTEREST IN
GUANGZHOU PHARMACEUTICALS CORPORATION
AND
GRANT OF PUT OPTIONS TO THE VENDOR TO SELL
20% OF THE EQUITY INTEREST IN
GUANGZHOU PHARMACEUTICALS CORPORATION
AND
RESUMPTION OF TRADING
|
